11.06.2024 - BOSTON, June 11, 2024 (GLOBE NEWSWIRE) - Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today . Seite 1
Inducement-plan
Nasdaq-listing-rule